The integrated role of desferrioxamine and phenserine targeted to an iron-responsive element in the APP-mRNA 5'-untranslated region.
about
Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer's diseaseAlzheimer's disease therapeutics targeted to the control of amyloid precursor protein translation: maintenance of brain iron homeostasisNovel 5' untranslated region directed blockers of iron-regulatory protein-1 dependent amyloid precursor protein translation: implications for down syndrome and Alzheimer's diseaseMetals and cholesterol: two sides of the same coin in Alzheimer's disease pathology.The alpha-synuclein 5'untranslated region targeted translation blockers: anti-alpha synuclein efficacy of cardiac glycosides and Posiphen.The anticholinesterase phenserine and its enantiomer posiphen as 5'untranslated-region-directed translation blockers of the Parkinson's alpha synuclein expressionLifespan profiles of Alzheimer's disease-associated genes and products in monkeys and miceCholinesterase inhibitors improve both memory and complex learning in aged beagle dogs.Transcriptional and post-transcriptional profile of human chromosome 21.Pharmacotherapeutic targets in Alzheimer's diseaseAmyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases.Neuroinflammation and copper in Alzheimer's disease.Metal chelators coupled with nanoparticles as potential therapeutic agents for Alzheimer's diseaseWas phenserine a failure or were investigators mislead by methods?Brain iron homeostasis: from molecular mechanisms to clinical significance and therapeutic opportunitiesThe promoter and the 5'-untranslated region of rice metallothionein OsMT2b gene are capable of directing high-level gene expression in germinated rice embryos.Translational inhibition of APP by Posiphen: Efficacy, pharmacodynamics, and pharmacokinetics in the APP/PS1 mouse.Role of amyloid-β–metal interactions in Alzheimer’s disease
P2860
Q24651822-F47F15BC-C65A-4763-9897-DA251738120DQ27024824-8F1B55BD-ECA8-4E43-A3F3-9077227107F9Q28535011-F34E78F2-B176-4369-85E3-778980243997Q33646882-E5EA908F-0001-4A69-9D28-171030C5EB8FQ33790013-291CC967-8BB1-406F-8C21-7F114EE699A9Q36012226-2C496D55-B80C-4AAB-A573-3C0A5ABBD01CQ36603312-D9C60AB3-1EF2-4F37-BCA5-ED512556B53EQ37163279-D8C31BF2-75D7-4465-BFF3-82333F796581Q37287384-384AA593-23F8-415A-B649-781AB074300FQ37295067-50C7557E-BF00-4E21-9A91-0A42D8CF33A4Q37376532-51944F28-1A99-4BFB-B062-3F949D45EAD9Q37393152-8C8FE8F1-C685-4C89-ADB7-D06BD99BB403Q37428097-BB36ECCA-6896-4E3B-B5A1-392900A4BF81Q37530878-B50CED6C-D0C5-498C-B41F-0A34D867E2ADQ37605018-3EDB0BE8-B6EC-44DF-BAD0-0B2B734BB908Q43760367-B580236C-C847-41DE-BEAE-09CDEF6335A9Q55418661-360D37F7-FF8D-4BDF-9230-659845F95F12Q58842294-F47CC50B-200F-4710-9983-4B00956D1C41
P2860
The integrated role of desferrioxamine and phenserine targeted to an iron-responsive element in the APP-mRNA 5'-untranslated region.
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
The integrated role of desferr ...... P-mRNA 5'-untranslated region.
@ast
The integrated role of desferr ...... P-mRNA 5'-untranslated region.
@en
type
label
The integrated role of desferr ...... P-mRNA 5'-untranslated region.
@ast
The integrated role of desferr ...... P-mRNA 5'-untranslated region.
@en
prefLabel
The integrated role of desferr ...... P-mRNA 5'-untranslated region.
@ast
The integrated role of desferr ...... P-mRNA 5'-untranslated region.
@en
P2093
P356
P1476
The integrated role of desferr ...... P-mRNA 5'-untranslated region.
@en
P2093
Amanda Venti
Debomoy K Lahiri
Jack T Rogers
Nigel H Greig
Tony Giordano
P356
10.1196/ANNALS.1332.003
P407
P577
2004-12-01T00:00:00Z